Unknown

Dataset Information

0

Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress.


ABSTRACT: Photodynamic therapy (PDT) is considered a pioneering and effective modality for cancer treatment, but it is still facing challenges of hypoxic tumors. Recently, Type I PDT, as an effective strategy to address this issue, has drawn considerable attention. Few reports are available on the capability for Type I reactive oxygen species (ROS) generation of purely organic photosensitizers (PSs). Herein, we report two new Type I PSs, α-TPA-PIO and β-TPA-PIO, from phosphindole oxide-based isomers with efficient Type I ROS generation abilities. A detailed study on photophysical and photochemical mechanisms is conducted to shed light on the molecular design of PSs based on the Type I mechanism. The in vitro results demonstrate that these two PSs can selectively accumulate in a neutral lipid region, particularly in the endoplasmic reticulum (ER), of cells and efficiently induce ER-stress mediated apoptosis and autophagy in PDT. In vivo models indicate that β-TPA-PIO successfully achieves remarkable tumor ablation. The ROS-based ER stress triggered by β-TPA-PIO-mediated PDT has high potential as a precursor of the immunostimulatory effect for immunotherapy. This work presents a comprehensive protocol for Type I-based purely organic PSs and highlights the significance of considering the working mechanism in the design of PSs for the optimization of cancer treatment protocols.

SUBMITTER: Zhuang Z 

PROVIDER: S-EPMC8515424 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Type I photosensitizers based on phosphindole oxide for photodynamic therapy: apoptosis and autophagy induced by endoplasmic reticulum stress.

Zhuang Zeyan Z   Dai Jun J   Yu Maoxing M   Li Jianqing J   Shen Pingchuan P   Hu Rong R   Lou Xiaoding X   Zhao Zujin Z   Tang Ben Zhong BZ  

Chemical science 20200302 13


Photodynamic therapy (PDT) is considered a pioneering and effective modality for cancer treatment, but it is still facing challenges of hypoxic tumors. Recently, Type I PDT, as an effective strategy to address this issue, has drawn considerable attention. Few reports are available on the capability for Type I reactive oxygen species (ROS) generation of purely organic photosensitizers (PSs). Herein, we report two new Type I PSs, <i>α</i>-TPA-PIO and <i>β</i>-TPA-PIO, from phosphindole oxide-based  ...[more]

Similar Datasets

| S-EPMC7494608 | biostudies-literature
| S-EPMC4423012 | biostudies-literature
| S-EPMC4718706 | biostudies-literature
| S-EPMC5505064 | biostudies-literature
| S-EPMC3092447 | biostudies-literature
| S-EPMC7498451 | biostudies-literature
| S-EPMC6689035 | biostudies-literature
| S-EPMC9851881 | biostudies-literature
| S-EPMC3927133 | biostudies-literature
| S-EPMC5571976 | biostudies-literature